Keyphrases
Prognostic Marker
100%
Advanced Ovarian Cancer
100%
MiR-200
100%
MicroRNA Cluster
100%
MicroRNA
77%
Ovarian Cancer
33%
Disease Outcome
22%
Non-coding RNA (ncRNA)
11%
Overexpression
11%
Overall Survival
11%
Patient Care
11%
Ovarian Tumor
11%
Expression Profile
11%
MiRNA Target
11%
In Cancer
11%
Prognostic Value
11%
Small Interfering RNA (siRNA)
11%
Ovarian Cancer Cells
11%
Outcome Prediction
11%
Tumor Development
11%
RNA Molecules
11%
Cancer Outcomes
11%
Human Cancer
11%
Cancer Recurrence
11%
Cancer Development
11%
Poor Survival
11%
Targeted Analysis
11%
Regulatory Role
11%
Multiple Genes
11%
Cancer Cell Migration
11%
MiRNA Expression
11%
Expression Profile Analysis
11%
PCR-based
11%
MiRNA Expression Profile
11%
Disease Outcome Prediction
11%
Novel Prognostic Biomarker
11%
MiR-429
11%
Immunology and Microbiology
Cell Migration
100%
Overall Survival
100%
Cancer Cell
100%
Prognostic Biomarker
100%
RNA Gene
100%
Medicine and Dentistry
microRNA
100%
Ovarian Cancer
100%
microRNA 200
100%
Diseases
36%
microRNA 200b
27%
Biological Marker
9%
Malignant Neoplasm
9%
Neoplasm
9%
Cancer
9%
Cancer Cell
9%
Overall Survival
9%
Ovarian Tumor
9%
Cancer Recurrence
9%
Cell Migration
9%
Untranslated RNA
9%
RNA Gene
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
microRNA
100%
microRNA 200
100%
Diseases
36%
microRNA 200b
27%
Neoplasm
9%
Malignant Neoplasm
9%
Biological Marker
9%
Overall Survival
9%
Cancer Recurrence
9%
Ovary Tumor
9%
Untranslated RNA
9%